Skip to main content

FAST Graphs helps investors visualize a company’s earnings, valuation, dividends, and historical performance in one clear research platform. Compare price with fundamentals, identify potential overvaluation or undervaluation, and make decisions with greater confidence.

Research the business behind the stock.

Explore FAST Graphs Today

Disclosure: This advertisement may contain an affiliate link. I may earn a commission at no additional cost to you.

RSP vs. SPY: The Six-Percentage-Point Valuation Gap That Could Define the Next Decade

The most important investment decision of the next decade might not be which stocks investors own.

It might be how much of each stock they own.

That's the fascinating argument emerging from new Bank of America valuation work comparing the traditional capitalization-weighted S&P 500 with its equal-weight counterpart.

The conclusion is striking.

Bank of America's normalized valuation model puts the traditional S&P 500 at approximately 32 times normalized earnings, a level historically associated with roughly negative 3% average annual returns over the following decade.

The S&P 500 Equal Weight Index, meanwhile, trades at approximately 25 times normalized earnings, which the same framework associates with roughly positive 3% annualized returns.

That's a six-percentage-point difference in projected annual performance.

Compounded over ten years, the implications become enormous.

And investors don't need to abandon the S&P 500 to make the switch.

They simply need to change how they weight it.

RSP vs. SPY: Same Companies, Very Different Portfolio

This is what makes the comparison between the Invesco S&P 500 Equal Weight ETF (RSP) and SPDR S&P 500 ETF Trust (SPY) so interesting.

Both are essentially built from the S&P 500 universe.

But SPY weights companies according to their float-adjusted market capitalization.

The bigger the company becomes, the larger its influence on the portfolio.

RSP does something fundamentally different.

The S&P 500 Equal Weight Index resets each company to approximately 0.2% of the index at each quarterly rebalance.

That sounds like a minor technical distinction.

It isn't.

It changes the entire character of the portfolio.

Look at What Has Happened to SPY

As of September 16, NVIDIA represented approximately 7.96% of SPY.

Apple represented another 7.50%.

Microsoft accounted for approximately 5.59%.

Amazon represented roughly 3.70%.

Add Alphabet, Broadcom, Meta, Micron and Tesla, and a remarkable portion of America's flagship stock index becomes dependent on a relatively small collection of enormous companies.

Technology alone represented approximately 38% of SPY as of September 16.

There is nothing inherently wrong with that.

Those companies became enormous because their businesses and stock prices performed extraordinarily well.

But it creates a concentration issue that investors sometimes overlook.

Owning 500 stocks doesn't necessarily mean your money is evenly diversified across 500 businesses.

SPY owns hundreds of companies.

Its performance can still be heavily influenced by a handful.

RSP Changes the Equation

RSP essentially says:

Why should a trillion-dollar company automatically deserve dozens of times more influence over my portfolio than another profitable S&P 500 company?

Equal weighting eliminates much of that concentration.

Instead of allowing winners to continuously become larger portions of the portfolio, the index periodically resets the weights.

That creates an interesting mechanical discipline.

The strategy effectively trims stocks that have outperformed their peers and reallocates capital toward stocks that have underperformed.

S&P Dow Jones Indices describes this quarterly process as resetting constituents to equal weight, which can allow the index to capture potential mean reversion while preventing the largest stocks from dominating indefinitely.

That rebalancing mechanism may become especially important when market leadership becomes unusually narrow.

The Valuation Gap Is the Real Story

Bank of America's analysis makes this debate particularly interesting because today's concentration has coincided with a substantial valuation difference.

According to the September 14 client note summarized by Business Insider:

S&P 500 normalized P/E: ~32

S&P 500 Equal Weight normalized P/E: ~25

Bank of America's historical model associates those valuations with:

Cap-weighted S&P 500: ~−3% annualized

Equal-weight S&P 500: ~+3% annualized

over the coming decade.

I wouldn't interpret those figures as literal forecasts.

A valuation model cannot tell us where stocks will trade next year, and it certainly cannot guarantee what investors will earn by 2036.

But the spread is difficult to ignore.

The argument isn't necessarily that the S&P 500 is doomed.

It's that investors may currently be paying substantially different prices for different parts of the same index.

The 80% Statistic Deserves Attention

Bank of America's normalized P/E model reportedly explains approximately 80% of subsequent ten-year returns historically.

That's an unusually strong historical relationship.

But there's an important distinction.

Valuation can be useful for estimating long-term expected returns while being almost useless for predicting what happens over the next six months.

An expensive market can become more expensive.

A cheap market can remain cheap.

And a handful of dominant companies can continue outperforming much longer than valuation models suggest they should.

That's why I wouldn't interpret this analysis as a market-crash warning.

I would interpret it as a capital-allocation warning.

The price investors pay still matters.

It Isn't Just One Valuation Model

The normalized P/E model isn't Bank of America's only warning signal.

According to the report, six of the firm's ten valuation measures currently imply negative long-term returns for the S&P 500.

Those measures include indicators such as the Shiller P/E and market-cap-to-GDP ratio.

Across all ten models, the average projected annual return is approximately:

−1.4%.

Again, these shouldn't be treated as destiny.

They're historical valuation relationships.

But when several different valuation frameworks point toward unusually low prospective returns, I think investors should at least ask whether concentration in the most expensive portion of the market has become excessive.

Why Equal Weight Could Win

There are several conditions under which RSP could outperform SPY.

The first is obvious:

Market Breadth Expands

If performance broadens beyond today's largest technology and AI companies, equal weighting should capture more of that participation.

A rally driven by industrials, financials, healthcare companies, consumer businesses and other less-dominant S&P constituents would naturally benefit RSP.

Megacap Valuations Compress

SPY's concentration becomes a liability if today's largest companies continue growing their businesses but experience declining valuation multiples.

Those companies don't need to collapse.

They simply need to underperform the rest of the index.

Economic Growth Broadens

Equal weighting gives substantially more economic importance to the average S&P 500 company.

If earnings growth becomes less concentrated among the largest technology companies, that could improve the relative outlook for RSP.

Mean Reversion Returns

RSP's quarterly rebalancing systematically reduces exposure to relative winners and increases exposure to relative laggards.

If market leadership rotates, that mechanism can become valuable.

But RSP Has Its Own Risks

Equal weighting isn't automatically superior diversification.

It creates different risks.

RSP gives considerably more influence to smaller S&P 500 companies than SPY does.

Those companies can be more cyclical.

They can also have weaker margins, smaller competitive moats and greater sensitivity to economic downturns.

And quarterly rebalancing means RSP repeatedly sells portions of outperforming companies.

Sometimes those winners keep winning.

Imagine systematically reducing exposure to extraordinary compounders simply because their share prices appreciated faster than everyone else's.

That's the uncomfortable side of equal weighting.

The Megacap Advantage Is Real

There is another reason I wouldn't abandon capitalization weighting completely.

Today's largest companies aren't merely expensive speculative businesses.

Many are extraordinarily profitable.

NVIDIA, Apple, Microsoft, Amazon, Alphabet, Broadcom and Meta collectively possess enormous cash-generating ability, powerful competitive positions and significant exposure to structural growth markets.

Bank of America itself acknowledges that historical valuation models may be overly pessimistic because today's S&P 500 companies have stronger balance sheets and potentially higher-quality earnings than companies represented in earlier historical periods.

That's an important caveat.

A P/E ratio of 25 or 30 doesn't necessarily mean what it meant several decades ago if the underlying businesses have structurally different profitability and capital requirements.

RSP Isn't Really an Anti-Tech Bet

This distinction is important.

Buying RSP doesn't mean betting against NVIDIA, Apple or Microsoft.

RSP still owns S&P 500 companies.

It simply refuses to let the biggest companies dominate the portfolio.

That makes RSP less of an anti-technology trade and more of a market-breadth trade.

The investor is essentially saying:

I still want America's largest companies.

I just don't want my portfolio's future determined disproportionately by the handful that have already become enormous.

The Hidden Rebalancing Advantage

One feature of equal weighting receives surprisingly little attention.

Every quarter, the index is forced to rebalance.

Suppose one stock rises substantially while another falls.

A capitalization-weighted index naturally allows the winner to become a larger percentage of the portfolio.

Equal weighting does the opposite during rebalancing.

It trims the winner and adds to the laggard.

That creates a systematic form of:

sell relatively high, buy relatively low.

It doesn't always work.

Momentum markets can punish that strategy because yesterday's winners frequently become tomorrow's winners.

But during periods of market rotation and valuation normalization, the discipline can become powerful.

RSP vs. SPY: The Real Decision

The question isn't whether one ETF contains better companies.

They draw from essentially the same S&P 500 constituent universe.

The question is what investors believe will drive the next decade.

If the future continues to be dominated by a handful of megacap technology companies, capitalization weighting could remain extremely difficult to beat.

If market leadership broadens and valuation matters more, equal weighting becomes increasingly compelling.

That's why the current valuation gap deserves attention.

My Long-Term View: BUY RSP

For investors looking specifically for broader S&P 500 exposure with less megacap concentration, my rating on RSP is:

BUY — Long-Term Diversification Play

I'm not making that call because I expect SPY to crash.

I'm making it because the relative valuation setup gives RSP an interesting long-term risk/reward profile.

Bank of America's numbers illustrate the argument particularly well:

Normalized valuation

SPY-style S&P 500: ~32×

Equal-weight S&P 500: ~25×

Historically implied 10-year annualized return

Cap weighted: ~−3%

Equal weighted: ~+3%

Those aren't guaranteed future returns.

But they represent a substantial enough valuation difference that I think investors should pay attention.

What Would Make the Thesis Wrong?

The most obvious answer is continued megacap dominance.

If AI spending produces extraordinary earnings growth for NVIDIA, Microsoft, Alphabet, Amazon and the other technology giants, their current valuations could eventually prove justified.

Under that environment, reducing their weights every quarter could become a persistent disadvantage for RSP.

A recession could also hurt the equal-weight index disproportionately because of its greater exposure to economically sensitive companies.

And valuation itself may remain a poor timing mechanism for years.

The market doesn't have to correct an imbalance simply because investors recognize one.

Bottom Line

RSP offers something deceptively simple.

The same broad collection of America's largest companies—but without allowing a handful of giants to control the portfolio.

The S&P 500 Equal Weight Index gives each company approximately 0.2% at quarterly rebalancing, while SPY currently has roughly 38% invested in information technology alone and substantial individual positions in NVIDIA, Apple and Microsoft.

That difference hasn't always mattered.

Over the next decade, it might matter enormously.

Bank of America's valuation analysis isn't predicting an imminent crash. It is raising a more interesting question:

What if the next decade rewards the stocks investors have been ignoring rather than the companies they've spent the last decade chasing?

If that happens, equal weighting won't need the Magnificent Seven to collapse.

It will simply need the other 490-plus companies to finally matter again.

And that's why I believe RSP deserves serious consideration as a long-term complement—or alternative—to traditional cap-weighted S&P 500 exposure.

Rating: BUY for long-term diversified U.S. equity exposure. Bank of America's return figures are valuation-model estimates based on historical relationships, not guaranteed returns or individualized investment advice.

Comments

Popular posts from this blog

Lennar Cut Construction Costs 6%—So Why Did Earnings Collapse 52%?

Lennar just demonstrated one of the strangest contradictions in the American housing market. The company is building homes faster. Construction costs are falling. Its land-light strategy is reducing the amount of capital trapped in land. Inventory management is improving. And yet earnings per share fell almost 48% , from $2.29 to $1.19. That isn't what operational improvement is supposed to look like. But Lennar's third-quarter 2026 results reveal something increasingly important about the housing market: America can simultaneously have a structural housing shortage and an affordability crisis severe enough to crush homebuilder profitability. That's exactly what appears to be happening. Lennar's Quarter in One Sentence Lennar produced approximately $8.0 billion in revenue , delivered 20,840 homes and generated 20,879 new orders during the quarter. But orders declined 9% year over year, deliveries declined 3%, and earnings deteriorated sharply. The comparison with last y...

Agilent Technologies: A “Long Runway” Bet on the Future of Therapeutics

Agilent Technologies: A “Long Runway” Bet on the Future of Therapeutics Byline: Market Analysis & Forecast When Agilent Technologies CEO Padraig McDonnell talks about a “long runway” in advancing therapeutics, he isn’t making a vague optimism play—he’s pointing directly at one of the most structurally durable growth trends in healthcare. And increasingly, the company is positioning itself to monetize that runway. The News Behind the Narrative McDonnell’s bullish tone comes as Agilent doubles down on its role in drug development infrastructure—particularly in diagnostics, pathology, and therapeutic manufacturing. Recent moves reinforce that thesis: Agilent launched Advanced Therapeutics , consolidating CDMO (contract development & manufacturing) capabilities across North America ( Yahoo Finance ) It is acquiring Biocare Medical for $950M , expanding its footprint in cancer diagnostics and pathology workflows ( Reuters ) The company continues to push into precision oncology and b...

Alico (ALCO): Hidden Land Value Play or Value Trap in Transition?

Byline: Market Analysis & Forecast Alico isn’t your typical stock—it’s not really an agriculture company anymore. Based on recent CEO commentary, it’s becoming something else entirely: 👉 a land monetization and real estate development story hiding inside an old citrus business And management is making that shift very clear. “We’ve built a balanced platform… to unlock substantial value from our ~46,000-acre portfolio.” Activate Up to $100 Cash Back That’s not subtle. The News: A Full-Blown Transformation Alico is exiting citrus operations and pivoting toward: Land sales Land leasing Real estate development This is a massive strategic shift. Key Highlights: Adjusted EBITDA: +$2.7M (vs -$6.7M last year) Land sales: $34.5M+ recent activity 97% of farmable land now leased Portfolio value: $650M–$750M (management estimate) Meanwhile: 👉 Market cap is roughly ~$300M range That gap is the entire thesis. The Investment Thesis: This Is a Land Arbi...